The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: The peptide with big claims and scant evidence STAT What Science ACTUALLY Says About BPC 157 Benefits FDA moves toward easing restrictions on certain peptides BioPharma Dive How different peptide therapies may affect your body Prenuvo blog